Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT)

v3.23.2
STOCKHOLDERS EQUITY (DEFICIT)
6 Months Ended
Jun. 30, 2023
STOCKHOLDERS EQUITY (DEFICIT)  
STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 6 - STOCKHOLDERS’ EQUITY (DEFICIT)

 

2021 Equity Incentive Plan

 

On October 12, 2021, after approval from the stockholders at the Company’s 2021 annual meeting of stockholders, the Company adopted the 2021 Plan for the purpose of enhancing the Company’s ability to attract and retain highly qualified directors, officers, key employees and other persons and to motivate such persons to improve the business results and earnings of the Company by providing an opportunity to acquire or increase a direct proprietary interest in the operations and future success of the Company. The 2021 Plan is administered by the compensation committee of the Board who will, amongst other duties, have full power and authority to take all actions and to make all determinations required or provided for under the 2021 Plan. Pursuant to the 2021 Plan, the Company may grant options, share appreciation rights, restricted shares, restricted share units, unrestricted shares and dividend equivalent rights. The 2021 Plan has a duration of 10 years.

 

Subject to adjustment as described in the 2021 Plan, the aggregate number of shares of common stock available for issuance under the 2021 Plan is initially set at 1,000,000 shares; this number is automatically increased each January 1st by an amount equal to 5% of the number of common stock shares outstanding at that date, resulting in an increase in available shares under the 2021 Plan at January 1, 2023 of 470,893. As of June 30, 2023, 1,392,675 options have been issued under the 2021 Plan, and 549,291 shares remained available for issuance.

 

2019 Omnibus Long-Term Incentive Plan

 

Prior to the adoption of the 2021 Equity Incentive Plan, the Company maintained a 2019 Omnibus Long-Term Incentive Plan (the “2019 Plan”). Following the approval by the shareholders of the 2021 Plan, no additional awards have been or will be made under the 2019 Plan. As of June 30, 2023, 781,250 stock options had been issued under the 2019 Plan with terms between 5 years and 10 years, of which 365,625 remained outstanding.

 

Common Stock Options

 

A summary of the status of the Company’s options issued under the Company’s equity incentive plans is presented below. As of June 30, 2023 there is no intrinsic value in any of the Company's outstanding options as the market price of the Company's common stock is in all cases lower than the exercise price of options:

 

 

 

June 30, 2023

 

 

June 30, 2022

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise

Price

 

 

Number of

Options

 

 

Weighted

Average

Exercise

Price

 

Outstanding, beginning of year

 

 

1,689,907

 

 

$ 6.05

 

 

 

1,721,074

 

 

$ 7.38

 

Forfeited

 

 

-

 

 

 

-

 

 

 

(761,625 )

 

 

6.81

 

Issued

 

 

65,268

 

 

 

2.79

 

 

 

172,500

 

 

 

5.50

 

Outstanding, end of period

 

 

1,755,175

 

 

$ 5.93

 

 

 

1,131,949

 

 

$ 7.48

 

Options outstanding and exercisable by price range as of June 30, 2023, were as follows:

 

Outstanding Options

 

 

Exercisable Options

 

Range of

Exercise Price

 

 

Number

 

 

Average

Weighted

Remaining

Contractual

Life in Years

 

 

Range of

Exercise Price

 

 

Number

 

 

Weighted

Average

Exercise Price

 

$

2.00-2.99

 

 

 

408,460

 

 

 

7.96

 

 

$

2.00-2.99

 

 

 

375,826

 

 

$ 2.76

 

3.00-3.99

 

 

 

220,391

 

 

 

9.15

 

 

3.00-3.99

 

 

 

78,794

 

 

 

3.79

 

4.00-4.99

 

 

 

53,324

 

 

 

8.29

 

 

4.00-4.99

 

 

 

53,324

 

 

 

4.48

 

5.00-5.99

 

 

 

710,500

 

 

 

8.39

 

 

5.00-5.99

 

 

 

485,250

 

 

 

5.50

 

8.00-8.99

 

 

 

6,250

 

 

 

2.04

 

 

8.00-8.99

 

 

 

6,250

 

 

 

8.80

 

9.00-9.99

 

 

 

25,000

 

 

 

2.13

 

 

9.00-9.99

 

 

 

25,000

 

 

 

9.60

 

11.00-11.99

 

 

 

162,500

 

 

 

7.31

 

 

11.00-11.99

 

 

 

100,000

 

 

 

11.20

 

12.00-12.99

 

 

 

168,750

 

 

 

1.64

 

 

12.00-12.99

 

 

 

168,750

 

 

 

12.80

 

 

 

 

 

 

1,755,175

 

 

 

7.52

 

 

 

 

 

 

 

1,293,194

 

 

$ 6.05

 

 

Common Stock Warrants - Unregistered

 

A summary of the status of the Company’s unregistered warrants is presented below:

 

 

 

June 30, 2023

 

 

June 30, 2022

 

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise

Price

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise

Price

 

Outstanding, beginning of year

 

 

1,602,198

 

 

$ 7.85

 

 

 

2,553,635

 

 

$ 7.57

 

Issued

 

 

390,000

 

 

 

2.91

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Expired

 

 

(598,518 )

 

$ 7.70

 

 

 

(28,591 )

 

 

6.45

 

Outstanding, end of period

 

 

1,393,680

 

 

$ 6.53

 

 

 

2,525,044

 

 

$ 7.57

 

 

Unregistered warrants outstanding and exercisable by price range as of June 30, 2023, were as follows:

 

Outstanding Warrants

 

 

Exercisable Warrants

 

Exercise Price

 

 

Number

 

 

Average

Weighted

Remaining

Contractual Life

in Years

 

 

Exercise

Price

 

 

Number

 

 

Weighted

Average

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2.00-2.99

 

 

 

390,000

 

 

 

2.76

 

 

$

2.00-2.99

 

 

 

390,000

 

 

$ 2.91

 

5.00-5.99

 

 

 

220,800

 

 

 

2.93

 

 

5.00-5.99

 

 

 

220,800

 

 

 

5.50

 

6.00-6.99

 

 

 

31,875

 

 

 

1.25

 

 

6.00-6.99

 

 

 

31,875

 

 

 

6.40

 

8.00-8.99

 

 

 

476,566

 

 

 

0.69

 

 

8.00-8.99

 

 

 

476,566

 

 

 

8.03

 

9.00-9.99

 

 

 

231,938

 

 

 

2.20

 

 

9.00-9.99

 

 

 

231,938

 

 

 

9.60

 

10.00-10.99

 

 

 

1,688

 

 

 

2.87

 

 

10.00-10.99

 

 

 

1,688

 

 

 

10.40

 

11.00-11.99

 

 

 

35,813

 

 

 

0.50

 

 

11.00-11.99

 

 

 

35,813

 

 

 

11.20

 

14.00-14.99

 

 

 

5,000

 

 

 

1.50

 

 

14.00-14.99

 

 

 

5,000

 

 

 

14.40

 

 

 

 

 

 

1,393,680

 

 

 

1.89

 

 

 

 

 

 

 

1,393,680

 

 

$ 6.53

 

Common Stock Warrants - Registered

 

A summary of the status of the Company’s registered warrants is presented below:

 

 

 

June 30, 2023

 

 

June 30, 2022

 

 

 

Number of

Registered Warrants

 

 

Weighted

Average

Exercise

Price

 

 

Number of

Registered Warrants

 

 

Weighted

Average

Exercise

Price

 

Outstanding, beginning of year

 

 

2,975,497

 

 

$ 5.50

 

 

 

2,975,497

 

 

$ 5.50

 

Issued

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, end of period

 

 

2,975,497

 

 

$ 5.50

 

 

 

2,975,497

 

 

$ 5.50

 

 

Registered warrants outstanding and exercisable by price range as of June 30, 2023, were as follows:

 

Outstanding Registered Warrants

 

 

Exercisable Registered Warrants

 

Exercise Price

 

 

Number

 

 

Average

Weighted

Remaining

Contractual Life

in Years

 

 

Exercise

Price

 

 

Number

 

 

Weighted

Average

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5.50

 

 

 

2,975,497

 

 

 

2.93

 

 

$ 5.50

 

 

 

2,975,497

 

 

 

5.50